TGFB2 and Oral leukoplakia: Among a cohort of 80 oral leukoplakias evaluated by IHC for immunomodulatory mediators, increased expression of HLA-G/E, IL10, TGFβ2/3 was noted when compared with oral carcinoma samples (27).